biodexapharma.com (BDRX) Cash Money per Share

Biodexa - graphic logo of issuer BDRX

Biodexa Pharmaceuticals (BDRX) is implementing green logistics and recyclable packaging to reduce its carbon footprint. The change in cash per share on the GURU.Markets chart demonstrates financial resilience, where the value 8.19 reflects the current level of reserves. Growth is driven by the success of eRapa in treating rare brain tumors, while patent protection for drug delivery technologies creates a significant barrier to entry for competitors.

Biodexa Pharma (BDRX) - Cash per Share from 04/28/2023 to 11/20/2026

Analytical breakdowns for Biodexa Pharmaceuticals

- market capitalization details:
- cash availability and cash flow indicators:
Summary company analysis:BDRX, Biodexa Pharmaceuticals PLC
Flagship merchandise of Biodexa Pharmaceuticals

Biodexa Pharmaceuticals attracts leading oncologists by providing them with full autonomy to develop innovative molecules. The current cash per share reflects the volume of liquid assets attributable to a single security. This metric allows for an assessment of the real value of capital, excluding market overvaluation. The stability of this indicator confirms the company's ability to fund costly research without emergency borrowings. A high liquidity reserve guarantees the stability of BDRX quotes.